Skip to content

Alignment Healthcare ALHC Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Par or Stated Value Per Share at other companies

Humana logo
HumanaHUM
CVS Health logo
CVS HealthCVS
UnitedHealth Group logo
UnitedHealth GroupUNH

Other financials

Income statement

See full
Revenue$1.2B+33.3%
Operating income$15.5M+387%
Net income$11.4M+225%
EPS (diluted)$0.05+200%

Balance sheet

See full
Cash & equivalents$707.7M+57.9%
Total debt$323.6M+0.5%
Total equity$206.9M+91.3%
Total assets$1.3B+40.9%

Cash flow

See full
Operating cash flow$128.7M+674%
CapEx$7.4M-10.8%
Free cash flow$121.3M+1,350%

Valuation

See full
Market cap$4.52B+0.8%

Profitability

See full
Operating margin0.1%0.0pp
Net margin0.5%+0.2pp
FCF margin4.1%

Returns & leverage

See full
Return on equity12.6%+6.8pp
Debt / equity1.6×-1.4×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Alignment Healthcare in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: Alignment Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alignment Healthcare's preferred stock, par or stated value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alignment Healthcare's preferred stock, par or stated value per share?
Alignment Healthcare (ALHC) reported preferred stock, par or stated value per share of $0 in Q1 2026.
How has Alignment Healthcare's preferred stock, par or stated value per share changed year-over-year?
Alignment Healthcare's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Alignment Healthcare's preferred stock, par or stated value per share?
Over 2 years (2023 to 2025), Alignment Healthcare's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.